Skip to main navigation

Investors & Media
Contact Us
Linkedin
Twitter

Overview
News & Events
- Press Releases
- Events & Presentations
Corporate Governance
Financial Information
- SEC Filings
- Annual Reports
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Investor Resources
Investors + Media
Medical Professionals
Contact Us
Linkedin
Twitter

Press Releases

Items Per Page

Year

09 Dec 2019

Researchers Present Preclinical Data Showing Synergistic Activity of SpringWorks Therapeutics’ Gamma Secretase Inhibitor (Nirogacestat) with GlaxoSmithKline’s BCMA Antibody-Drug Conjugate (Belantamab Mafodotin) at the American Society of Hematology (ASH)

PDF Version

12 Nov 2019

SpringWorks Therapeutics Reports Third Quarter 2019 Financial Results and Recent Business Highlights

PDF Version

24 Oct 2019

SpringWorks Therapeutics Announces Initiation of Phase 2b ReNeu Clinical Trial of Mirdametinib in Children and Adults with Neurofibromatosis Type 1 (NF1)-Associated Plexiform Neurofibromas (NF1-PN)

PDF Version

24 Sep 2019

European Commission Grants Orphan Drug Designation for Nirogacestat for the Treatment of Soft Tissue Sarcoma

PDF Version

17 Sep 2019

SpringWorks Therapeutics Announces Closing Of Initial Public Offering and Exercise in Full of the Underwriter’s Option to Purchase Additional Shares

PDF Version

12 Sep 2019

SpringWorks Therapeutics Announces Pricing Of Initial Public Offering

PDF Version

30 Aug 2019

SpringWorks Therapeutics Appoints Alan Fuhrman to Its Board of Directors

PDF Version

29 Aug 2019

SpringWorks Therapeutics Receives Breakthrough Therapy Designation for Nirogacestat for the Treatment of Adult Patients with Progressive, Unresectable, Recurrent or Refractory Desmoid Tumors

PDF Version

15 Aug 2019

SpringWorks Therapeutics Announces Appointment of Frank Perier as Chief Financial Officer

PDF Version

30 Jul 2019

European Commission Grants Orphan Drug Designation for SpringWorks Therapeutics’ MEK Inhibitor, Mirdametinib, for the Treatment of Neurofibromatosis Type 1

PDF Version

Pagination

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Current page 7
Page 8
Page 9
Next page
Last page

Displaying 61 - 70 of 85

Springworks - Toolkits

Print Page
Email Alerts
RSS Feeds
Investor Contacts

Request E-mail Alerts

Social Links

Who We Are
Focus Areas

Pipeline
Careers
- View Opportunities

Patients
Contact

Investors & Media

© 2022 SpringWorks Therapeutics. All rights reserved.

Copyright Links

Privacy Policy
Terms of Use